Mayo Clinic's Clinical Trial Matching Project Sees Higher Enrollment in Breast Cancer Trials through Use of Artificial Intelligence

Mayo Clinic and IBM Watson Health (NYSE: IBM) have unveiled results from early use of the Watson for Clinical Trial Matching, an IBM cognitive computing system. Use of this system in the Mayo Clinic oncology practice has been associated with more patients enrolled in Mayo’s breast cancer clinical trials.
Source: eHealth News EU - Category: Information Technology Tags: Featured IBM Healthcare Business and Industry Source Type: news